CCAAT/enhancer-binding protein β promotes osteoblast differentiation by enhancing Runx2 activity with ATF4

Molecular Biology of the Cell

Volumn 19, Issue 12, 2008, Pages 5373-5386

  Tominaga, Hiroyuki ^a,d   Maeda, Shingo ^a,d   Hayashi, Makoto ^a   Takeda, Shu ^b   Akira, Shizuo ^c   Komiya, Setsuro ^d   Nakamura, Takashi ^e   Akiyama, Haruhiko ^e   Imamura, Takeshi ^a  

^a CANCER INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGEN TYPE 10; HETERODIMER; HOMODIMER; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL MATURATION; CONTROLLED STUDY; GENE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; TRANSACTIVATION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; BONE AND BONES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; PROMOTER REGIONS, GENETIC;

MUS;

EID: 59449103777     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-03-0329     Document Type: Article

References (35)

1. Albrecht, U., Eichele, G., Helms, J. A., and Lu, H. C. (1997). Visualization of gene expression patterns by in situ hybridization. In: Molecular and Cellular Methods in Developmental Toxicology, ed. G. P. Daston, Boca Raton: CRC Press 23-48.
2. Aubin, J. E., Lian, J. B., and Stein, G. S. (2006). Bone formation: maturation and function activities of osteoblast lineage cells. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th ed., ed. J. Favus, Washington: American Society for Bone and Mineral Research, 20-29.
3. Bachner, D., Ahrens, M., Schroder, D., Hoffmann, A., Lauber, J., Betat, N., Steinert, P., Flohe, L., and Gross, G. (1998). Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev. Dyn. 213, 398-411.
4. Bai, T., Tanaka, T., Yukawa, K., Umesaki, N., Matsumoto, M., and Akira, S. (2006). Impaired postnatal development in C/EBPβ-deficient mice. J. Reprod. Dev. 52, 645-649.
5. Conlon, R. A., and Rossant, J. (1992). Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development 116, 357-368.
6. Dobreva, G., Chahrour, M., Dautzenberg, M., Chirivella, L., Kanzler, B., Farinas, I., Karsenty, G., and Grosschedl, R. (2006). SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125, 971-986.
7. Ducy, P., and Karsenty, G. (1995). Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15, 1858-1869.
8. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. (1997). Osf2/Cbfa1, a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
9. Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., and Miyazono, K. (2001). Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477-12480.
10. Gutierrez, S., Javed, A., Tennant, D. K., van Rees, M., Montecino, M., Stein, G. S., Stein, J. L., and Lian, J. B. (2002). CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277, 1316-1323.
11. Harrison, J. R., Huang, Y. F., Wilson, K. A., Kelly, P. L., Adams, D. J., Gronowicz, G. A., and Clark, S. H. (2005). Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein β (C/EBPβ), a truncated C/EBPβ isoform, causes osteopenia in transgenic mice. J. Biol. Chem. 280, 8117-8124.
12. Hata, K., Nishimura, R., Ueda, M., Ikeda, F., Matsubara, T., Ichida, F., Hisada, K., Nokubi, T., Yamaguchi, A., and Yoneda, T. (2005). A CCAAT/enhancer binding protein β isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol. Cell. Biol. 25, 1971-1979.
13. Kaneshiro, K., Tsutsumi, S., Tsuji, S., Shirahige, K., and Aburatani, H. (2007). An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 89, 178-188.
14. Komori, T. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
15. Mundlos, S. et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779.
16. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., and de Crombrugghe, B. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
17. Ogasawara, A., Arakawa, T., Kaneda, T., Takuma, T., Sato, T., Kaneko, H., Kumegawa, M., and Hakeda, Y. (2001). Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP β, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 276, 7048-7054.
18. Otto, F. et al. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771.
19. Pereira, R. C., Delany, A. M., and Canalis, E. (2002). Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 30, 685-691.
20. Podust, L. M., Krezel, A. M., and Kim, Y. (2001). Crystal structure of the CCAAT box/enhancer-binding protein β activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA. J. Biol. Chem. 276, 505-513.
21. Screpanti, I. et al. (1995). Lymphoproliferative disorder and imbalanced T-helper response in C/EBP β-deficient mice. EMBO J. 14, 1932-1941.
22. Shin, C. S., Jeon, M. J., Yang, J. Y., Her, S. J., Kim, D., Kim, S. W., and Kim, S. Y. (2006). CCAAT/enhancer-binding protein δ activates the Runx2-mediated transcription of mouse osteocalcin II promoter. J. Mol. Endocrinol. 36, 531-546.
23. Shirakawa, K. et al. (2006). CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation. Mol. Cell. Biol. 26, 6105-6116.
24. Takeda, S., Bonnamy, J. P., Owen, M. J., Ducy, P., and Karsenty, G. (2001). Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467-481.
25. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., and Kishimoto, T. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361.
26. Tanaka, T., Yoshida, N., Kishimoto, T., and Akira, S. (1997). Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J. 16, 7432-7443.
27. Ueta, C. et al. (2001). Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153, 87-100.
28. Vallejo, M., Ron, D., Miller, C. P., and Habener, J. F. (1993). C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA 90, 4679-4683.
29. Wu, Z., Xie, Y., Bucher, N. L., and Farmer, S. R. (1995). Conditional ectopic expression of C/EBP β in NIH-3T3 cells induces PPAR γ and stimulates adipogenesis. Genes Dev. 9, 2350-2363.
30. Xiao, G., Jiang, D., Ge, C., Zhao, Z., Lai, Y., Boules, H., Phimphilai, M., Yang, X., Karsenty, G., and Franceschi, R. T. (2005). Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J. Biol. Chem. 280, 30689-30696.
31. Yang, X. et al. (2004). ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117, 387-398.
32. Yu, S., Jiang, Y., Galson, D. L., Luo, M., Lai, Y., Lu, Y., Ouyang, H. J., Zhang, J., and Xiao, G. (2008). General transcription factor IIA-γ increases osteoblast-specific Osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2. J. Biol. Chem. 283, 5542-5553.
33. Yu, V. W., Ambartsoumian, G., Verlinden, L., Moir, J. M., Prud'homme, J., Gauthier, C., Roughley, P. J., and St-Arnaud, R. (2005). FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell Biol. 169, 591-601.
34. Zhao, M., Qiao, M., Oyajobi, B. O., Mundy, G. R., and Chen, D. (2003). E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation. J. Biol. Chem. 278, 27939-27944.
35. Zheng, Q., Zhou, G., Morello, R., Chen, Y., Garcia-Rojas, X., and Lee, B. (2003). Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 162, 833-842.